Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Venous Thromboembolism Is Associated with Inferior Survival after Allogeneic Hematopoietic Cell Transplant

Lauren M. Granat, Lisa A. Rybicki, Mailey L. Wilks, Christina Ferraro, Matt Kalaycio, Ronald M. Sobecks, Navneet S. Majhail, Dana E. Angelini, Betty K. Hamilton

Blood (2021) 138 (Supplement 1): 4866.

https://doi.org/10.1182/blood-2021-151230

Published: 2021

Journal Articles

Randomized Trial of Tacrolimus and Methotrexate Versus Tacrolimus, Reduced Dose Methotrexate, and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease after Myeloablative Related and Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Betty K. Hamilton, Lisa A. Rybicki, Taylor Lucas, Donna Corrigan, Matt Kalaycio, Rabi Hanna, Seth J Rotz, Robert M. Dean, Aaron T. Gerds, Brian T. Hill, Deepa Jagadeesh, Brad Pohlman, Edward A. Copelan, Navneet S. Majhail

Blood (2021) 138 (Supplement 1): 99.

https://doi.org/10.1182/blood-2021-149686

Published: 2021

Journal Articles

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: Secondary Analysis of Two Randomized Controlled Trials on Survivorship Care Plans

Rajshekhar Chakraborty, Lisa A. Rybicki, Jaime M. Preussler, Steven Devine, K. Scott Baker, Karen Syrjala, Jean C. Yi, Jennifer L Whitten, Bronwen E. Shaw, Navneet S. Majhail

Blood (2021) 138 (Supplement 1): 431.

https://doi.org/10.1182/blood-2021-149281

Published: 2021

Journal Articles

Community Health Status and Long-Term Outcomes in 1-Year Survivors of Autologous and Allogeneic Hematopoietic Cell Transplantation

Julia H. Joo, Sanghee Hong, Lisa A. Rybicki, Betty K. Hamilton, Navneet S. Majhail

Blood (2021) 138 (Supplement 1): 422.

https://doi.org/10.1182/blood-2021-148035

Published: 2021

Journal Articles

Once Weekly Subcutaneous Bortezomib, Cyclophosphamide, and Dexamethasone As Induction Therapy for All AL Amyloidosis

Hashim Abbas, Lisa A. Rybicki, MS, Frederic J. Reu, MD, Christy Samaras, DO, Mitchell R. Smith, Debbie Hastings, Jason Valent, MD

Blood (2016) 128 (22): 5813.

https://doi.org/10.1182/blood.V128.22.5813.5813

Published: 2016

Journal Articles

Comparative Effectiveness of Fludarabine and Busulfan Versus Fludarabine and 400 cGy Total Body Irradiation Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation for AML/MDS

Moaath Mustafa Ali, MD, Donna M Abounader, Lisa A. Rybicki, MS, Melissa A Yurch, Jamie Starn, RN, BSN, Christina Ferraro, RN, BSN, Victoria Winslow, RN, BSN, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Hien Liu, MD, Robert Dean, Brian T. Hill, MD PhD, Brad Pohlman, MD, Steven Andresen, DO, Rabi Hanna, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS, Ronald Sobecks, MD

Blood (2015) 126 (23): 1920.

https://doi.org/10.1182/blood.V126.23.1920.1920

Published: 2015

Journal Articles

Long-Term Outcomes after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia

Moaath Mustafa Ali, MD, Donna M Abounader, Lisa A. Rybicki, MS, Jamie Starn, RN, BSN, Christina Ferraro, RN, BSN, Victoria Winslow, RN, BSN, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Hien Liu, MD, Robert M. Dean, MD, Rabi Hanna, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Anjali Advani, MD, Navneet S. Majhail, MD MS, Ronald Sobecks, MD

Blood (2015) 126 (23): 5534.

https://doi.org/10.1182/blood.V126.23.5534.5534

Published: 2015

Journal Articles

Association of Socioeconomic Status (SES) with Outcomes of Autologous Hematopoietic Cell Transplantation (ASCT) for Lymphoma

Sanghee Hong, MD, Lisa A. Rybicki, MS, Donna M Abounader, Brian J. Bolwell, MD, Robert M. Dean, MD, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Brian T. Hill, MD PhD, Deepa Jagadeesh, MD MPH, Matt Kalaycio, MD, Hien K. Liu, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Navneet S. Majhail, MD MS

Blood (2015) 126 (23): 4494.

https://doi.org/10.1182/blood.V126.23.4494.4494

Published: 2015

Journal Articles

Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide (Bu/Cy/VP) Produces Comparable Outcomes to 4-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)

Brian T. Hill, MD PhD, Lisa A. Rybicki, MS, Catherine Weber, PharmD, Deepa Jagadeesh, MD MPH, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Hien K. Liu, MD, Robert M. Dean, MD, Ronald M. Sobecks, MD, Brad Pohlman, MD, Steven Andresen, DO, Matt Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS

Blood (2015) 126 (23): 1987.

https://doi.org/10.1182/blood.V126.23.1987.1987

Published: 2015

Journal Articles

Standard Duration of Varicella Zoster Virus Prophylaxis May be Inadequate to Prevent Viral Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Front-Line Bendamustine Plus Rituximab

Joshua M. Allen, MD, Lisa A. Rybicki, MS, Paolo F. Caimi, MD, Deepa Jagadeesh, MD MPH, Robert M. Dean, MD, Brad Pohlman, MD, Mitchell R. Smith, MD PhD, Matt Kalaycio, MD, Brian T. Hill, MD PhD

Blood (2015) 126 (23): 4167.

https://doi.org/10.1182/blood.V126.23.4167.4167

Published: 2015

Journal Articles

Prognostic Impact of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes: Adverse Impact of TET2 Mutations

Betty K. Hamilton, MD, Navneet S. Majhail, MD MS, Cassandra M Hirsch, Bartlomiej Przychodzen, MSc, Lisa A. Rybicki, MS, Marcos De Lima, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Aaron T. Gerds, MD MS, Ronald Sobecks, MD, Rabi Hanna, MD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2015) 126 (23): 740.

https://doi.org/10.1182/blood.V126.23.740.740

Published: 2015

Journal Articles

Prognostic Value of Pre-Transplant PET Scan in Patients with Diffuse Large B-Cell (DLBCL) Lymphoma Undergoing Autologous Stem Cell Transplantation (ASCT)

Allison M Winter, MD, Lisa A. Rybicki, MS, Shetal Shah, MD, Deepa Jagadeesh, MD MPH, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Hien Liu, MD, Robert M. Dean, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Steven Andresen, DO, Mitchell R. Smith, MD PhD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS, Brian T. Hill, MD PhD

Blood (2015) 126 (23): 5495.

https://doi.org/10.1182/blood.V126.23.5495.5495

Published: 2015

Journal Articles

Secular Trends of Blood Stream Infections in the 72 Hours Prior to Death in Allogeneic Hematopoietic Cell Transplant Recipients

Shylaja Mani, MD, Lisa A. Rybicki, MS, Navneet S. Majhail, MD MS, Sherif Mossad, MD

Blood (2014) 124 (21): 3891.

https://doi.org/10.1182/blood.V124.21.3891.3891

Published: 2014

Journal Articles

Bulky Disease Does Not Adversely Affect Overall Survival in Early Stage Hodgkin Lymphoma: Role of Interim PET and Possible Omission of Radiotherapy in Select Patients

Priyanka A Pophali, MD, Lisa A. Rybicki, MS, Kathleen B Fenner, MSHS, Deepa Jagadeesh, MD MPH, Robert M Dean, MD, Brad Pohlman, MD, Mitchell R. Smith, MD PhD, Brian T. Hill, MD PhD

Blood (2014) 124 (21): 4428.

https://doi.org/10.1182/blood.V124.21.4428.4428

Published: 2014

Journal Articles

A Randomized Study Of Music Therapy In Patients Undergoing Autologous Stem Cell Transplant: Decrease In Narcotic Medication Use For Pain Control

Blood (2013) 122 (21): 1693.

https://doi.org/10.1182/blood.V122.21.1693.1693

Published: 2013

Journal Articles

Hematogones Contained in CD34+ Apheresis Products for Hematopoietic Progenitor Cell Transplantation Have No Adverse Impact On Engraftment Outcomes.

Sarah L. Ondrejka, DO, Eric D. Hsi, MD, Lisa A. Rybicki, MS, Deborah A. Katanik, Brian J. Bolwell, MD, Hien K. Duong, MD

Blood (2012) 120 (21): 3022.

https://doi.org/10.1182/blood.V120.21.3022.3022

Published: 2012

Journal Articles

An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737

Sayer Al-harbi, Brian T. Hill, Suparna Mazumder, Kamini Singh, Jennifer DeVecchio, Gaurav Choudhary, Lisa A. Rybicki, Matt Kalaycio, Jaroslaw P. Maciejewski, Janet A. Houghton, Alexandru Almasan

Blood (2011) 118 (13): 3579–3590.

https://doi.org/10.1182/blood-2011-03-340364

Published: 2011

Includes: Supplemental data

Journal Articles

Prior Therapy with Rituximab (R) in Patients with Follicular Lymphoma (FL) Does Not Affect Relapse-Free (RFS) or Overall Survival (OS) after High Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT).

Tyler Y. Kang, MD, John William Sweetenham, MD, Snehal G. Thakkar, MD, Lisa A. Rybicki, MS, Stacey Brown, Robert Dean, MD, Mikkael A. Sekeres, MD, MS, Anjali Advani, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Brad Pohlman, MD, Brian J. Bolwell, MD

Blood (2006) 108 (11): 3069.

https://doi.org/10.1182/blood.V108.11.3069.3069

Published: 2006

Journal Articles

Altered Expression and Activity of Topoisomerases During All- Trans Retinoic Acid-Induced Differentiation of HL-60 Cells

Masako Aoyama, Dale R. Grabowski, Richard J. Isaacs, Kim A. Krivacic, Lisa A. Rybicki, Ronald M. Bukowski, Mahrukh K. Ganapathi, Ian D. Hickson, Ram Ganapathi

Blood (1998) 92 (8): 2863–2870.

https://doi.org/10.1182/blood.V92.8.2863

Published: 1998

NARROW

Venous Thromboembolism Is Associated with Inferior Survival after Allogeneic Hematopoietic Cell Transplant

Randomized Trial of Tacrolimus and Methotrexate Versus Tacrolimus, Reduced Dose Methotrexate, and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease after Myeloablative Related and Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: Secondary Analysis of Two Randomized Controlled Trials on Survivorship Care Plans

Community Health Status and Long-Term Outcomes in 1-Year Survivors of Autologous and Allogeneic Hematopoietic Cell Transplantation

Once Weekly Subcutaneous Bortezomib, Cyclophosphamide, and Dexamethasone As Induction Therapy for All AL Amyloidosis

Comparative Effectiveness of Fludarabine and Busulfan Versus Fludarabine and 400 cGy Total Body Irradiation Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation for AML/MDS

Long-Term Outcomes after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia

Association of Socioeconomic Status (SES) with Outcomes of Autologous Hematopoietic Cell Transplantation (ASCT) for Lymphoma

Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide (Bu/Cy/VP) Produces Comparable Outcomes to 4-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)

Standard Duration of Varicella Zoster Virus Prophylaxis May be Inadequate to Prevent Viral Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Front-Line Bendamustine Plus Rituximab

Prognostic Impact of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes: Adverse Impact of TET2 Mutations

Prognostic Value of Pre-Transplant PET Scan in Patients with Diffuse Large B-Cell (DLBCL) Lymphoma Undergoing Autologous Stem Cell Transplantation (ASCT)

Secular Trends of Blood Stream Infections in the 72 Hours Prior to Death in Allogeneic Hematopoietic Cell Transplant Recipients

Bulky Disease Does Not Adversely Affect Overall Survival in Early Stage Hodgkin Lymphoma: Role of Interim PET and Possible Omission of Radiotherapy in Select Patients

A Randomized Study Of Music Therapy In Patients Undergoing Autologous Stem Cell Transplant: Decrease In Narcotic Medication Use For Pain Control

Hematogones Contained in CD34+ Apheresis Products for Hematopoietic Progenitor Cell Transplantation Have No Adverse Impact On Engraftment Outcomes.

An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737

Prior Therapy with Rituximab (R) in Patients with Follicular Lymphoma (FL) Does Not Affect Relapse-Free (RFS) or Overall Survival (OS) after High Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT).

Altered Expression and Activity of Topoisomerases During All- Trans Retinoic Acid-Induced Differentiation of HL-60 Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only